Lexeo Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q3 2023 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Lexeo Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q3 2023 to Q2 2024.
  • Lexeo Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending June 30, 2024 was $2.15M.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.15M Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $2.34M Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.55M Dec 31, 2023 10-K 2024-03-11
Q3 2023 $2.76M Sep 30, 2023 10-Q 2023-12-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.